<b><i>Background/Aims:</i></b> Previous studies indicate that patients with the parkinsonian subtype of multiple system atrophy (MSA-P) experience cognitive impairment. This study aimed to identify the existence of cognitive impairments and the different topographic patterns of morphological changes in MSA-P by means of imaging analysis, and also whether these morphological changes could be associated with cognitive dysfunctions in MSA-P. <b><i>Methods:</i></b> We recruited 15 nondemented probable MSA-P patients and 32 normal controls (NC) for neuropsychological testing and MRI. We analyzed morphological changes using cortical thickness analysis, voxel-based morphometry (VBM) and cerebellar volumetry. Multiple linear regression analysis was...
Abstract Multiple system atrophy (MSA) is characterized by a variable combination of cerebellar atax...
<p><strong>Objective </strong> To explore the characteristics of executive dysfunction of patients ...
Cognitive impairment is one of the most salient non-motor symptoms of Parkinson ’ s disease (PD). Co...
Imaging and neuropathology studies have demonstrated significant abnormalities not only in subcortic...
Purpose: Cognitive impairment in Parkinson disease (PD) related with the fronto-striatal dysfunction...
Introduction: Cognitive deficits and neuropsychiatric symptoms occur in parkinsonian and cerebellar ...
none14siCurrent consensus diagnostic criteria for multiple system atrophy (MSA) consider dementia a ...
BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associ...
BACKGROUND: Cognitive dysfunction is common in Parkinson's disease (PD), and along with PD with deme...
Context: Cognitive impairments are common in patients with Parkinson's disease (PD) and are heteroge...
Introduction: Mild cognitive impairment (MCI) is common in Parkinson’s disease (PD), but the underly...
International audienceContext : Cognitive impairments are common in patients with Parkinson’s diseas...
BackgroundRecent reports show that dementia occurs in 5?26% of multiple system atrophy (MSA) patient...
BACKGROUND: Cortical neural correlates of ongoing cognitive decline in Parkinson's disease (PD) ha...
BACKGROUND: Parkinson's disease with mild cognitive impairment (PD-MCI) is a heterogeneous entity in...
Abstract Multiple system atrophy (MSA) is characterized by a variable combination of cerebellar atax...
<p><strong>Objective </strong> To explore the characteristics of executive dysfunction of patients ...
Cognitive impairment is one of the most salient non-motor symptoms of Parkinson ’ s disease (PD). Co...
Imaging and neuropathology studies have demonstrated significant abnormalities not only in subcortic...
Purpose: Cognitive impairment in Parkinson disease (PD) related with the fronto-striatal dysfunction...
Introduction: Cognitive deficits and neuropsychiatric symptoms occur in parkinsonian and cerebellar ...
none14siCurrent consensus diagnostic criteria for multiple system atrophy (MSA) consider dementia a ...
BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associ...
BACKGROUND: Cognitive dysfunction is common in Parkinson's disease (PD), and along with PD with deme...
Context: Cognitive impairments are common in patients with Parkinson's disease (PD) and are heteroge...
Introduction: Mild cognitive impairment (MCI) is common in Parkinson’s disease (PD), but the underly...
International audienceContext : Cognitive impairments are common in patients with Parkinson’s diseas...
BackgroundRecent reports show that dementia occurs in 5?26% of multiple system atrophy (MSA) patient...
BACKGROUND: Cortical neural correlates of ongoing cognitive decline in Parkinson's disease (PD) ha...
BACKGROUND: Parkinson's disease with mild cognitive impairment (PD-MCI) is a heterogeneous entity in...
Abstract Multiple system atrophy (MSA) is characterized by a variable combination of cerebellar atax...
<p><strong>Objective </strong> To explore the characteristics of executive dysfunction of patients ...
Cognitive impairment is one of the most salient non-motor symptoms of Parkinson ’ s disease (PD). Co...